Forward to a colleague  July 2003   Volume 1, No. 2 
  In This Issue  
Pharmacy Issues in Multivitamin Infusion
Guidelines for Preparing M.V.I.-12®
Standard Label Templates
  Archive  
March Newsflash
March 25, 2004
Vol. 2 No. 2
January Newsflash
January 27, 2004
Vol. 2 No. 1
December Newslines
December 16, 2003
Vol. 9 No. 4
November Newsflash
November 27, 2003
Vol. 1 No. 4
October Newsflash
October 15, 2003
Vol. 1 No. 4
September Newslines
September 29, 2003
Vol. 9 No. 3
August Newsflash
September 11, 2003
Vol. 1 No. 3
June Newslines
June 25, 2003
Vol. 9 No. 2
May Newsflash
May 13, 2003
Vol. 1 No. 1
April Newslines
April 10, 2003
Vol. 9 No. 1

[MORE]
  Subscribe
 
Click here to opt in to the monthly M.V.I.® email program

Headline News
Pharmacy Issues in Multivitamin Infusion

The nutrition support pharmacist plays a critical role in the overall management of patients receiving parenteral nutrition and multivitamin infusion. Because vitamins are important cofactors in numerous metabolic pathways, vitamin deficiencies can have a rate-limiting effect on healing and tissue repair. Therefore, it is important for pharmacists (as well as other nutrition support professionals) to be aware of the four principal chemical degradation pathways that may lead to vitamin loss during TPN.

[FULL STORY]
 


TPN Tools and Tables
Guidelines for Preparing M.V.I.-12®

All forms of M.V.I.-12® are easy and convenient to use. To read our recommended guidelines for preparing it, click here.
 

Standard Label Templates

The following label templates are available to facilitate your practice:

Note: These materials are in PDF format and require Adobe Acrobat Reader® to view them. Click here to download Adobe Acrobat Reader ®
 
  Relevant Links  
 
Prescribing Information
M.V.I. Pediatric®
M.V.I.- 12®
Aquasol A®

Our web sites:
www.mvi-us.com
www.aaiPharma.com

  Contact Us  
 
If you would like to comment on an article or ask a question, please click_here.

For ordering information,
click here.

 
  Forward to a colleague M.V.I.® Home  Privacy Statement 
Published by Mayne Pharma